Evaluating hepatotoxic effects of chemotherapeutic agents with gadoxetic-acid-enhanced magnetic resonance imaging
- 1 March 2020
- journal article
- research article
- Published by Elsevier in European Journal of Radiology
- Vol. 124, 108807
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Consistency of hepatocellular gadoxetic acid uptake in serial MRI examinations for evaluation of liver functionAbdominal Radiology, 2019
- Nothing But NET: A Review of Neuroendocrine Tumors and CarcinomasNeoplasia, 2017
- Visualization of Hepatic Uptake Transporter Function in Healthy Subjects by Using Gadoxetic Acid–enhanced MR ImagingRadiology, 2012
- A LC–MS/MS method to evaluate the hepatic uptake of the liver-specific magnetic resonance imaging contrast agent gadoxetate (Gd-EOB-DTPA) in vitro and in humansJournal of Chromatography B, 2012
- The long‐term outcome of patients with polycystic liver disease treated with lanreotideAlimentary Pharmacology & Therapeutics, 2011
- Drug-Induced Acute Liver FailureHepatology, 2010
- A Multicenter, Randomized, Double-Blind Trial of EverolimusVersusAzathioprine and Placebo to Maintain Steroid-Induced Remission in Patients With Moderate-to-Severe Active Crohn's DiseaseAmerican Journal of Gastroenterology, 2008
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous5-fluorouracil/leucovorinAnnals of Oncology, 2002
- A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancerAnnals of Oncology, 1997